Keyphrases
Idiotype
60%
T Cells
55%
B-cell Lymphoma
54%
Tumor Cells
50%
GPI-anchored Protein (GPI-AP)
42%
Tumor
40%
Vaccination
37%
Tumor Growth
33%
Lymphoma
31%
Bispecific Antibody
30%
Anti-idiotypic Antibody
29%
Transmembrane
29%
CD58
28%
Thy-1
26%
Anti-idiotype
21%
Spleen Cells
21%
Dendritic Cells
21%
LFA-1
21%
Immunoregulatory Factors
21%
Monoclonal Antibody
20%
Rituximab
19%
Cell Surface
19%
Myeloma
19%
Anti-CD20 Antibody
19%
Lymphocytes
18%
Immune Response
17%
T Cell Activation
17%
B Cells
17%
Lymphoid Organs
17%
B Lymphocytes
16%
Supernatant
15%
Synergistic Effect
15%
Potentiation
15%
Immunoglobulin
14%
Adhesion Molecules
14%
Dendritic Cell Vaccine
14%
Enhancement Effect
14%
LFA-3
14%
Environmental Enrichment
14%
Enhancing Factors
14%
Phosphatidylinositol
14%
B Cell Receptor
14%
Cell Activity
14%
Cytolysis
13%
Mixed Lymphocyte Culture
12%
Natural Killer Cell Activity
12%
Metastasis
12%
Tumor Rejection
12%
Syngeneic
12%
Cell-based
11%
Immunology and Microbiology
B Cell
100%
T Cell
78%
Idiotype
55%
Antiidiotypic Antibody
44%
Tumor Cell
38%
Cell Adhesion Proteins
36%
Bispecific Antibody
29%
Dendritic Cell
28%
Cell Surface
25%
Immunotherapy
25%
Cell Function
23%
Splenocyte
22%
Lymphocyte Function-Associated Antigen 1
21%
Lymphocyte
20%
Immune Response
19%
Monoclonal Antibody
19%
Intravenous Immunoglobulin
19%
Immunoglobulin M
18%
Target Cell
18%
Secretion (Process)
18%
Wild Type
17%
Cell Adhesion
17%
Cross Linking
16%
Rituximab
16%
CD20 Antibody
16%
Signal Transduction
15%
Light Chain
15%
Heavy Chain
14%
Lymphocyte Function Associated Antigen 3
14%
Conditioning
14%
Lymphoid Organ
14%
Mixed Lymphocyte Reaction
13%
Interleukin 2
11%
Cell Line
11%
Mixed Lymphocyte Culture
11%
Lectin
11%
Glycan
11%
Tumor Rejection
11%
Syngenic
10%
Cytotoxic T Cell
10%
Lymphokine
10%
Precursor
10%
Blocking Antibody
10%
Lymph Node
9%
Dendritic Cell Vaccine
9%
Cell Membrane
9%
Multiple Myeloma
9%
T Cell Proliferation
9%
Supernatant
9%
Mitogen
8%